Clinical Trial Update: Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ramucirumab in advanced or metastatic biliary cancers that cannot be removed surgically; results completed and posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Liver and Intrahepatic Bile Duct Carcinoma

Drugs mentioned

• Ramucirumab (ramucirumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-15